Topics

Latest Ear, Nose & Throat NewsRSS

03:28 EDT 20th September 2019 | BioPortfolio

An electronic nose device that detects chemicals in the breath can identify with 85% accuracy those patients who will or will not respond to the latest #Cancer #immunotherapies: http://ow.ly/YAKv50wfa5m pic.twitter.com/yEdWjOiXJI

An electronic nose device that detects chemicals in the breath can identify with 85% accuracy those patients who will or will not respond to the latest #Cancer #immunotherapies: http://ow.ly/YAKv50wfa5m  pic.twitter.com/yEdWjOiXJI

2019 Throat Infection Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Published by VPA Research] Prices from USD $1799

The global clinical trial report 2019 Throat Infection Clinical Trials Study provides complete list of trials completed, ongoing and planned for Throat Infection. It presents indepth analysis of Throat Infection clinical trials across markets and companies. The research work is for providing complete understanding into trends in Throat Infection. The report covers a key snapshot of trial trends, ...

If you could get a vaccination that would prevent cancer - would you?

Since September is Gynecological Cancer Awareness Month, Dr. Michael Ulm, Gynecologic Oncologist at West Cancer Center & Research Institute, is urging everyone under the age of 45 to get a vaccination that can help prevent six different types of cancer. MEMPHIS, Tenn. (PRWEB) September 18, 2019 The human papillomavirus is a sexually transmitted infection that can cause cervical cancer, vulvar...

Breathalyzer Sniffs Out Potential Cancer Immunotherapy Responders

A prospective trial by researchers in the Netherlands has shown that an electronic nose device that detects chemicals in breath can identify with 85% accuracy those NSCLC patients who will or will not respond to the latest immunotherapies. The eNose outperformed current gold standard IHC testing for the PD-L1 biomarker. The post Breathalyzer Sniffs Out Potential Cancer Immunotherapy Responders ap...

Lyra Therapeutics Adds Vineeta Belanger, Ph.D., as Senior Vice President of Clinical Affairs

Experienced leader brings clinical expertise as Lyra advances its development program in chronic rhinosinusitis Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing medicines designed to precisely target ear, nose and throat (ENT) diseases, today announced that Vineeta Belanger, Ph.D., will join as the company’s Senior Vice President of Clinical Affairs. She brings twenty...

Case-based learning: sore throat

Most sore throats are caused by viral infections and get better within a week through self-care. However, it is important to recognise when a sore throat is a symptom of a more serious illness.

Breath test to reduce overprescribing of antibiotics

‘Electronic nose’ can tell difference between bacterial and viral illness within five minutes

Modernizing Medicine to Showcase All-in-One ENT EHR Capabilities at AAO-HNSF 2019 Annual Meeting and OTO Experience

ENT practices can experience improved clinical and business operations by using modmed Otolaryngology Specialty-specific healthcare information technology leader Modernizing Medicine® announced it will showcase the latest enhancements to its award-w

Wedderspoon Debuts New Bee Propolis Throat Spray Line with Monofloral Manuka Honey at Natural Products Expo East 2019

U.S. Leader of Genuine Manuka Honey Unveils Unique Functional Format Combining the Power of Propolis and Manuka to Soothe and Promote Oral Health Wedderspoon, passionate steward of authentic Manuka Honey-based products and the #1 selling Manuka Honey brand in the U.S., will debut a new line of functional wellness products, Bee Propolis Throat Sprays with Monofloral Manuka Honey, at Natural Prod...

Lyra Therapeutics Appoints Ann Merrifield to Its Board of Directors

Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing medicines designed to precisely target ear, nose and throat (ENT) diseases, today announced the appointment of Ann Merrifield to its Board of Directors. Ms. Merrifield is an accomplished leader in the life science in

Novus Therapeutics to Participate in Two Upcoming Investor Conferences

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced that the company will participate in two upcoming investor conferences in New York City. H.C. Wainwright 21st Annual Global Investment Conference Lotte New York Palace Hotel September 8-10, 2019 Presentation: S...

Could That Chronic Cough and Throat Burn Be Silent Reflux?

More than 10% of Americans have silent reflux (LPR) and many don’t know it. Dr. Rao, a Denver-area physician, shares symptoms, diagnostic testing and a non-medicine, non-surgical alternative treatment for silent reflux. A Centennial patient shares her story of finally finding relief with a natural health solution. DENVER (PRWEB) August 27, 2019 Overindulging over the last official holiday of th...

Improving health outcomes for children requires us to look at the big picture

It was a simple chief complaint: sore throat and fever. As expected, the little girl’s rapid Strep was positive. Instructions given. Antibiotics sent. This was Peds 101. But for some reason, before mom walked out the door, she made mention of their stay at the shelter. Although I had seen this child many times before, […] Find jobs at Careers by KevinMD.com. Search thousands of physician...

Partnerships, Licensing, Investments and MA Deals and Trends for January 2019 in Pharmaceuticals [Published by Global Data] Prices from USD $1000

Partnerships, Licensing, Investments and MA Deals and Trends for January 2019 in PharmaceuticalsSummaryGlobalData's "Partnerships, Licensing, Investments and MA Deals and Trends for January 2019 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions MAs and financings in the pharmaceuticals industry. The report provides de...

Meniere Disease Pipeline Review, H1 2019 [Published by Global Markets Direct] Prices from USD $2000

Meniere Disease Pipeline Review, H1 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meniere Disease Pipeline Review, H1 2019, provides an overview of the Meniere Disease Ear Nose Throat Disorders pipeline landscape.Meniere disease is a disorder of the inner ear that causes spontaneous episodes of vertigo. Signs and symptoms of Meniere disease are he...

Evaluating the first NHS-funded sore throat test and treat service in the UK

In Wales, people with a sore throat may be offered advice and symptomatic treatment free of charge in community pharmacies through the common ailment service (CAS). However, antibiotics cannot be supplied and this can limit patients’ perceived value of the service. As a result, some patients continue to seek a GP appointment when they have a sore throat.

Novus Therapeutics Reports Second Quarter 2019 Financial Results

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced financial results for the quarter ended June 30, 2019. Operational Highlights Announced results from three OP0201 phase 1 safety clinical trials Presented OP0201 data at the 20th International Symposium on...

A 72-year-old British man whose partial dentures apparently got stuck in his throat during surgery and weren’t discovered for eight days. https://buff.ly/2Kyp7IW 

A 72-year-old British man whose partial dentures apparently got stuck in his throat during surgery and weren’t discovered for eight days. https://buff.ly/2Kyp7IW 

A 72-year-old man went to the ER because he was having a hard time swallowing. Doctors found partial dentures stuck in his throat; they had been there for eight days, following surgery. https://buff.ly/2H11k1U pic.twitter.com/oR1MaRXPoi

A 72-year-old man went to the ER because he was having a hard time swallowing. Doctors found partial dentures stuck in his throat; they had been there for eight days, following surgery. https://buff.ly/2H11k1U  pic.twitter.com/oR1MaRXPoi

Missing dentures found stuck in throat 8 days after surgery

A 72-year-old man went to the ER because he was having a hard time swallowing. Doctors found partial dentures stuck in his throat; they had been there for eight days,…

Ragweed Pollen Allergy Pipeline Review, H1 2019 [Published by Global Markets Direct] Prices from USD $2000

Ragweed Pollen Allergy Pipeline Review, H1 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ragweed Pollen Allergy Pipeline Review, H1 2019, provides an overview of the Ragweed Pollen Allergy Immunology pipeline landscape.Ragweed allergy occurs when ragweed pollen in the air enters the nose and throat of people who are allergic to that pollen, it can...

Global Cefetamet Pivoxil Tablets Market Research Report 20122024 [Published by HeyReport] Prices from USD $2170

SummaryThe global Cefetamet Pivoxil Tablets market will reach xxx Million USD in 2019 with CAGR xx% 20192024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.Based on products type, the report descr...

Partnerships, Licensing, Investments and MA Deals and Trends in Pharmaceuticals Q4 2018 [Published by Global Data] Prices from USD $1500

Partnerships, Licensing, Investments and MA Deals and Trends in Pharmaceuticals Q4 2018SummaryGlobalData's "Partnerships, Licensing, Investments and MA Deals and Trends in Pharmaceuticals Q4 2018", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions MAs and financings in the pharmaceuticals industry. The report provides detailed informati...

Partnerships, Licensing, Investments and MA Deals and Trends for February 2019 in Pharmaceuticals [Published by Global Data] Prices from USD $1000

Partnerships, Licensing, Investments and MA Deals and Trends for February 2019 in PharmaceuticalsSummaryGlobalData's "Partnerships, Licensing, Investments and MA Deals and Trends for February 2019 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions MAs and financings in the pharmaceuticals industry. The report provides ...

Nasal Polyps Nasal Polyposis Pipeline Review, H1 2019 [Published by Global Markets Direct] Prices from USD $2000

Nasal Polyps Nasal Polyposis Pipeline Review, H1 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyps Nasal Polyposis Pipeline Review, H1 2019, provides an overview of the Nasal Polyps Nasal Polyposis Ear Nose Throat Disorders pipeline landscape.Nasal polyps Nasal polyposis is an inflammatory condition develops in the nasal lining of nose. T...

Quick Search

review and buy Ear, Nose & Throat market research data and corporate reports here